- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06237855
Investigating the Feasibility and Outcomes of Patient Self-Drain Removal After Ventral Hernia Repair (SDR)
April 25, 2024 updated by: Wake Forest University Health Sciences
Empowering Patients: A Randomized Controlled Trial (RCT) Investigating the Feasibility and Outcomes of Patient Self-Drain Removal After Ventral Hernia Repair
The goal of this randomized controlled trial is to teach patients to safely and effectively self-remove drains at home in adults (aged 18 and older) following a ventral hernia repair (VHR).
Researchers will compare the group of subjects self-removing the drain at home to a control group of standard of care drain removal during a clinic visit by a provider to see if subjects are able to safely self-remove the drain at home.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Annually, in the United States, it is estimated that 500,000 ventral hernia repairs (VHRs) are performed with a cost in excess of $3.2 billion.
Drains are frequently used in an effort to prevent seroma formation.
Seromas are defined as a buildup of bodily fluid in a potential space post-surgery, usually at the surgical site.
Rate of seroma has been estimated to be between 9-11% following abdominal wall reconstruction (AWR).
The timing of the removal is usually after discharge but before patient's scheduled postoperative visit, thus most patients must call and speak to a health provider and come in for an additional clinic visit specifically for drain removal.
The goal of this study is to teach patients to safely and effectively self-remove drains at home.
This will allow patients to forgo the cost associated with commuting to the clinic, the clinic cost associated with nursing time and scheduling, the clinic visit, physician or nurse time to remove the drain and possibly lost wages for the patient from time off work.
It is important to note that self-drain removal will not compromise or deviate from typical patient follow up.
Instead, this will eliminate an extra patient visit when inevitably the timing of drain removal does not align with the typical follow-up period.
Additionally, this will allow providers to see additional patient consultations or perform other duties, as they will not have the time constraints associated with in-office drain removal.
This study will show that patient self-drain removal benefits the patients, the providers, and healthcare system without compromising patient safety, satisfaction, and postoperative care.
Study Type
Interventional
Enrollment (Estimated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Greg Scarola, MS
- Phone Number: 704-355-5379
- Email: Gregory.Scarola@AtriumHealth.org
Study Contact Backup
- Name: Todd Heniford, MD
- Phone Number: 704-355-2000
- Email: Todd.Heniford@AtriumHealth.org
Study Locations
-
-
North Carolina
-
Charlotte, North Carolina, United States, 28204
- Carolinas Laparoscopic & Advanced Surgery Program
-
Principal Investigator:
- Todd Heniford, MD
-
Contact:
- Gregory Scarola, MS
- Phone Number: 704-355-5766
- Email: Gregory.Scarola@atriumhealth.org
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Aged ≥18 years.
- Undergoing elective ventral hernia repair (VHR).
- Sub-cutaneous drain placement.
- Anticipated Centers for Disease Control and Preventions (CDC) 1&2 wound class.
Exclusion Criteria:
- Patients who do not have access to the online training video.
- The surgeon does not believe the patient can self-remove the drain.
- Planned concomitant procedures.
- Current mesh infection.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Standard of Care
Drain removal will occur during clinic visit by provider per standard of care procedure.
|
|
Experimental: Self-drain removal training
Subjects will remove drain at home Training will consist of a detailed online video of a provider instructing how to remove the drain and practicing on a model created specifically to mimic the following actions during drain self-removal:
|
Subjects will be trained to self-remove drain at home following ventral hernia repair.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Success rate of patients self-removing drains
Time Frame: 2 weeks post-operatively
|
Percentage of patients that are able to safely self-remove drain at home.
|
2 weeks post-operatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Wound complication rate
Time Frame: 30-days post-operatively.
|
Comparison of the wound complication rate between the control and intervention groups.
Wound complications will be defined as wound breakdown, wound cellulitis, hematoma, wound infection, and seroma requiring intervention.
Each wound complication will be reported individually and as an aggregate wound complication overall rate.
|
30-days post-operatively.
|
Change in drain removal training survey scores from pre to post training
Time Frame: Hour 1
|
Change in drain removal training survey scores from pre to post training.
The same survey is given pre and post is training and is on a 5-point Likert scale survey with 1 representing "strongly disagree" and 5 representing "strongly agree".
Higher scores indicate more confidence in the self-drain removing process.
|
Hour 1
|
Post-drain removal satisfaction survey scores
Time Frame: 30-days post-operatively
|
Score on satisfaction survey following self-drain removal (intervention group only).
Survey is on a 5-point Likert scale survey with 1 representing "strongly disagree" and 5 representing "strongly agree".
Higher scores indicate greater satisfaction with at home self-drain removal.
|
30-days post-operatively
|
Difference In Subject Costs
Time Frame: 30-days post-operatively
|
Difference in cost associated with reduction in clinic visits.
|
30-days post-operatively
|
Difference in Subject Amount of Time
Time Frame: 30-days post-operatively
|
Difference in time associated with reduction in clinic visits and travel
|
30-days post-operatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Todd Heniford, MD, Wake Forest University Health Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
July 1, 2024
Primary Completion (Estimated)
December 1, 2024
Study Completion (Estimated)
April 1, 2025
Study Registration Dates
First Submitted
January 15, 2024
First Submitted That Met QC Criteria
January 31, 2024
First Posted (Actual)
February 2, 2024
Study Record Updates
Last Update Posted (Estimated)
April 26, 2024
Last Update Submitted That Met QC Criteria
April 25, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00100883
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ventral Hernia
-
Varazdin General HospitalCompletedIncisional Ventral Hernia | Recurrent Ventral HerniaCroatia
-
Anne Arundel Health System Research InstituteMedtronic - MITGCompletedGrade I Ventral Hernia | Grade II Ventral HerniaUnited States
-
Sofregen Medical, Inc.TerminatedVentral Hernia RepairUnited States
-
University Hospital, Strasbourg, FranceRecruitingVentral Hernia RepairFrance
-
Makassed General HospitalSuspended
-
Zaza DemetrashviliRecruitingLarge Midline Ventral HerniaGeorgia
-
Hvidovre University HospitalUniversity of CopenhagenCompleted
-
Hvidovre University HospitalCopenhagen University Hospital at HerlevCompleted
-
Universitaire Ziekenhuizen KU LeuvenBelgian Section for Abdominal Wall Surgery, section of the Royal Belgian...Not yet recruitingVentral Incisional Hernia
-
University of PennsylvaniaCompleted
Clinical Trials on Self-drain removal
-
IRCCS San RaffaeleCompletedPancreatic Fistula | Complication,Postoperative | PROMs | Pancreas DiseaseItaly
-
Peking Union Medical College HospitalPeking University First Hospital; Cancer Institute and Hospital, Chinese Academy... and other collaboratorsCompletedDrainage | PancreaticoduodenectomyChina
-
Peking Union Medical College HospitalUnknownPancreatectomy | Post Procedural DischargeChina
-
University of British ColumbiaUnknown
-
Centre Hospitalier Universitaire, AmiensCompletedPancreatic Neoplasms | Pancreatic DiseaseFrance
-
Technische Universität DresdenGerman Cancer Research CenterRecruiting
-
Universitaire Ziekenhuizen KU LeuvenCompletedBreast Cancer | Draining Wound
-
Universita di VeronaCompletedAbdominal Abscess | Pancreatic Fistula | Pancreaticoduodenectomy | Distal PancreatectomyItaly
-
Centre hospitalier de l'Université de Montréal...WithdrawnHead and Neck Neoplasms | Drain Site Complication | Neck Dissection
-
University of FoggiaCompletedQuality of Life | Safety Issues